Results 51 to 60 of about 13,301,732 (374)

Recurrent bleeding after rubber band ligation diagnosed as mild hemophilia B: a case report and literature review

open access: yesBMC Surgery, 2022
Background Hemophilia is a recessive hemorrhagic disease relevant to X chromosome. In mild hemophilia cases, spontaneous bleeding is rare and the blood clotting function is normal, but severe bleeding may occur after trauma or surgery.
Xiaoying Jiang   +4 more
doaj   +1 more source

Development of a Clinical Candidate AAV3 Vector for Gene Therapy of Hemophilia B.

open access: yesHuman Gene Therapy, 2020
Although recombinant adeno-associated virus serotype 8 (AAV8) and serotype 5 (AAV5) vectors have shown efficacy in Phase 1 clinical trials for gene therapy of hemophilia B, it has become increasingly clear that these serotypes are not optimal for ...
Harrison C. Brown   +7 more
semanticscholar   +1 more source

Total Hip Arthroplasty for Avascular Necrosis in a Patient With Hemophilia B. [PDF]

open access: yesArthroplast Today
Avascular necrosis (AVN) of the femoral head accounts for up to 10% of all total hip arthroplasties performed annually. Typically associated with intravascular coagulation, AVN is extremely rare in patients with bleeding disorders such as hemophilia B ...
Dandamudi S   +4 more
europepmc   +2 more sources

Molecular genetic study of hemophilia B in an Algerian population [PDF]

open access: yes, 2017
Hemophilia B is inherited as x-linked recessive disorder, carried by females, where males are affected.Rare cases of females affected with hemophilia B are known.
Abla, Zidani   +4 more
core   +2 more sources

Preclinical evaluation of a next-generation, subcutaneously administered, coagulation factor IX variant, dalcinonacog alfa.

open access: yesPLoS ONE, 2020
IntroductionThe rapid clearance of factor IX necessitates frequent intravenous administrations to achieve effective prophylaxis for patients with hemophilia B.
Timothy C Nichols   +4 more
doaj   +1 more source

Cardiac surgery in patients with Hemophilia:is it safe?

open access: yesJournal of Cardiothoracic Surgery, 2020
Background The life expectancy of hemophiliacs is similar to that of the general population. As a result, the prevalence of age-related cardiovascular diseases has increased.
Amjad Shalabi   +9 more
doaj   +1 more source

Association of psychological and physical health with quality of life in patients with haemophilia: a brief review [PDF]

open access: yes
Hemophilia is an inherited bleeding disorder that is caused by an x-linked deficiency of clotting factors VIII in hemophilia A and IX in hemophilia B.
Choudhry, Dimple   +4 more
core   +2 more sources

Anti-CD20 as the B-Cell Targeting Agent in a Combined Therapy to Modulate Anti-Factor VIII Immune Responses in Hemophilia a Inhibitor Mice [PDF]

open access: yes, 2014
Neutralizing antibody formation against transgene products can represent a major complication following gene therapy with treatment of genetic diseases, such as hemophilia A.
Carol H. Miao   +4 more
core   +1 more source

A Case of Heel Reconstruction with a Reverse Sural Artery Flap in a Hemophilia B Patient [PDF]

open access: yesArchives of Plastic Surgery, 2012
Hemophilia B is a rare blood coagulation disorder. Complications such as bleeding and hematoma can cause necrosis of flaps, wound disruption, and the disturbance of wound healing.
Byung Kwon Lee, Jeong Su Shim
doaj   +2 more sources

Endothelial cells derived from patients' induced pluripotent stem cells for sustained factor VIII delivery and the treatment of hemophilia A. [PDF]

open access: yes, 2020
Hemophilia A (HA) is a bleeding disorder characterized by spontaneous and prolonged hemorrhage. The disease is caused by mutations in the coagulation factor 8 gene (F8) leading to factor VIII (FVIII) deficiency.
Agu, Emmanuel   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy